|
|
|
Volumn , Issue , 2010, Pages 353-362
|
|
An update on antibody reduction and rejection reversal following bortezomib use: a report of 52 cases across 10 centers.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALLOANTIBODY;
BORONIC ACID DERIVATIVE;
BORTEZOMIB;
IMMUNOSUPPRESSIVE AGENT;
PROTEASOME;
PROTEINASE INHIBITOR;
PYRAZINE DERIVATIVE;
ACUTE DISEASE;
ARTICLE;
BLOOD;
CHRONIC DISEASE;
DOWN REGULATION;
DRUG ANTAGONISM;
DRUG EFFECT;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
IMMUNOLOGY;
METABOLISM;
TIME;
TRANSPLANTATION;
TREATMENT OUTCOME;
ACUTE DISEASE;
BORONIC ACIDS;
CHRONIC DISEASE;
DOWN-REGULATION;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
ISOANTIBODIES;
PROTEASE INHIBITORS;
PROTEASOME ENDOPEPTIDASE COMPLEX;
PYRAZINES;
TIME FACTORS;
TRANSPLANTS;
TREATMENT OUTCOME;
|
|
EID: 79960074641
PISSN: 08909016
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (12)
|
|
References (0)
|
